CARCINOMATOUS MENINGITIS - CLINICAL MANIFESTATIONS AND MANAGEMENT

Citation
B. Zachariah et al., CARCINOMATOUS MENINGITIS - CLINICAL MANIFESTATIONS AND MANAGEMENT, International journal of clinical pharmacology and therapeutics, 33(1), 1995, pp. 7-12
Citations number
47
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
09461965
Volume
33
Issue
1
Year of publication
1995
Pages
7 - 12
Database
ISI
SICI code
0946-1965(1995)33:1<7:CM-CMA>2.0.ZU;2-3
Abstract
Carcinomatous meningitis (CM) is a cause of significant morbidity and mortality in patients with cancer. During the past 15 years, diffuse l eptomeningeal metastases of extracranial malignant tumors have been in creasingly reported [Wasserstrom et al. 1982, Theodore and Gendelman 1 981, Little et al. 1974, Olson et al. 1974, Yaphey et al. 1978, Sorens en et al. 1984], CM is increasing in frequency because of improved sur vival of patients with systemic anti neoplastic therapies and increase d awareness of this problem among physicians. In this review, we will be discussing the epidemiology, etiology, pathology, pathophysiology, clinical manifestations, diagnosis and management of carcinomatous men ingitis, as well as the status of recent basic and clinical investigat ions.